Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

STERLING MEDICAL ASSOCIATES, INC Cincinnati OH 45219 USA

UEI: SLED_B800E9D3F3989D50

STERLING MEDICAL ASSOCIATES, INC Cincinnati OH 45219 USA is a federal contractor, registered under UEI SLED_B800E9D3F3989D50. It has been awarded $86,130,376 across 1 federal contract. Primary work spans Unknown NAICS. Top awarding agencies include W40M Mrco Europe.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_B800E9D3F3989D50

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
W40M Mrco Europe$86.1M100%
Awards by NAICS
- Unknown NAICS$86.1M100%
Awards by Agency Over Time
Awards by Place of Performance

Open opportunities in STERLING MEDICAL ASSOCIATES, INC Cincinnati OH 45219 USA's top NAICS codes and agencies

NAICS: 325413
Federal
Blood Chemistry Testing - Cost Per Reportable Result
Solicitation # W9114F-26-Q-A009
The Medical Readiness Contracting Office-Europe plans to award a Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to provide an automated clinical chemistry analyzer system, including all necessary equipment, reagents, consumables, controls, and maintenance services, to support hematology testing at the U.S. Army Health Clinic in Vicenza, Italy. This contract will operate under a Cost Per Reportable Result (CPRR) contract line item number structure, covering a two-month phase-in period from January 2 through February 28, 2026, followed by a main ordering period extending from March 1, 2026, to December 31, 2030. The solicitation is aligned with NAICS code 324513 (In-Vitro Diagnostic Substance Manufacturing) and applies a Lowest Price Technically Acceptable (LPTA) evaluation process under Simplified Acquisition Procedures with full and open competition. Vendors are required to be registered in the System for Award Management (SAM) prior to quote submission, with the Request for Quotes (RFQ) expected to be posted around November 5, 2025. The contract scope entails delivering a fully integrated, FDA-approved random-access chemistry analyzer capable of handling diverse specimen types with automated barcode reading compliant with CLSI standards. The system must reliably support the estimated annual workload of over 42,000 clinical chemistry tests, providing timely results with minimal downtime through features such as uninterrupted power supply and water system integration. The contractor is responsible for supply chain management of reagents and consumables, maintaining quality control consistency with limited annual lot changes, and meeting rigorous inspection criteria at government acceptance sites, including shelf life and storage temperature standards. Compliance with federal and DoD cybersecurity, privacy laws (including HIPAA), RMF authorizations, and data breach reporting protocols is mandatory, with annual privacy training required for personnel. Although specific contract clauses, detailed pricing, and submission instructions are forthcoming with the RFQ, the contract emphasizes operational continuity, regulatory compliance, and strict quality standards essential to laboratory mission readiness at the Vicenza facility.
W40M Mrco Europe

POSTED

10 months ago

DEADLINE

N/A
View Details